Overview

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This observational, multicenter, prospective study will evaluate the use of bevacizumab in real clinical practice in chinese patients with metastatic colorectal cancer.
Details
Lead Sponsor:
Peking University
Treatments:
Bevacizumab